跳至主要内容
临床试验/NCT05233904
NCT05233904Unknown不适用

DART: Diagnostic-CT-Enabled Planning: A Randomized Trial in Palliative Radiation Therapy

Lawson Health Research Institute2 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2022年6月8日最近更新:
适应症

试验速览

阶段
不适用
入组人数
33
试验地点
2
主要终点
Time in Centre (TIC) on Treatment Day

研究概览

简要总结

The objective of this trial is to assess the efficacy, acceptability, and scalability of diagnostic-CT-enabled planning, compared to conventional CT simulation planning.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Able to provide informed consent
  • Patient has consented to PRT to bone/soft tissue metastases or primary targets in the thorax, abdomen, or pelvis and RO will use simple planning techniques (i.e. parallel-opposed pair or direct field beam arrangement)
  • Patient will be scheduled for same-day simulation and treatment (if randomized to Arm 1)
  • Patient has a pre-existing and recent (i.e. within 4 weeks of time of enrollment) diagnostic CT or CT-fused scan with full visualization of the region-of-interest which has been acquired from an approved diagnostic scanner
  • Patient positioning scan is deemed acceptable and reproducible (e.g., patient is lying supine and relatively flat, there is no/minimal motion blur, ect.)
  • Intravenous (IV)/oral contrast in the region-of-interest is permitted as long as it does not create artifact which obscured the target volume (density override calculations may be required)

排除标准

  • Any contraindication to receiving radiation
  • Oncologic emergencies and/or on-call cases
  • Pregnant or lactating women
  • Cases requiring composite dosimetric planning to account for previous radiotherapy or extended distance set-up

结局指标

主要结局

Time in Centre (TIC) on Treatment Day

时间窗: 1 Treatment Day

This is defined as the total time in hours spent at the cancer centre from the scheduled CT simulation (Arrm 1) or treatment delivery (Arm 2) appointment until beam delivery completion.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Palma

Principle Investigator

Lawson Health Research Institute

研究点 (2)

Loading locations...

相似试验